Request Deal Involvement
CBC Group and Mubadala completed the acquisition of the Chinese neurology and allergy business of UCB for $680m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Freshfields Bruckhaus Deringer
financial advisors
Lazard
financial advisors
PJT Partners
legal advisors
Clifford Chance
pr advisors
FGS Global
financial advisors
PJT Partners
legal advisors
Clifford Chance
or
Principals
target
UCB PHARMA SA (CHINESE NEUROLOGY AND ALLERGY BUSINESS)
vendor
UCB PHARMA SA
bidder
MUBADALA INVESTMENT COMPANY
bidder
CBC GROUP
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite